Weekly Compounding Pharmacy Reads

News Roundup

1. Zepbound Approved for Obstructive Sleep Apnea: The FDA has approved tirzepatide (Zepbound, Eli Lilly) as the first prescription medicine for adults with obstructive sleep apnea. This is a significant development for the treatment of this common sleep disorder, and it could have a major impact on pharmacies as they begin to dispense this new medication.   

2. Congress Passes Telehealth Extensions: Congress has passed legislation that extends telehealth flexibilities through 2025. This is good news for patients who rely on telehealth for access to care, and it will also help to support the continued growth of telehealth services.   

3. Pharmacists Lead Treatment for Opioid Use Disorder in Federal Prisons: Pharmacists are playing a leading role in the treatment of opioid use disorder in federal prisons. This is an important step in addressing the opioid crisis, and it could help to reduce recidivism rates among former inmates.   
   

4. Initial Federal Spending Deal Includes ASHP Priorities: The initial federal spending deal includes several priorities for the American Society of Health-System Pharmacists (ASHP). This is a positive development for the pharmacy profession, and it could lead to increased funding for important pharmacy programs and services.   
   

5. DEA Extends Telemedicine Flexibilities: The DEA has announced the extension of current telemedicine flexibilities for prescription-controlled medications through the end of 2025. This includes substances such as buprenorphine and Adderall. This is a significant development for patients who rely on telemedicine to access these medications.

Featured Article

Featured Video

Thank you!